US FDA releases CBD enforcement policy update in Congress
13th March 2020 - News analysis |
The Food and Drug Administration (FDA) has released an update on CBD enforcement to members of Congress
The Food and Drug Administration (FDA) has released an update on CBD enforcement to members of Congress
Companies are beginning to show interest in Kazakhstan ahead of an anticipated liberalisation of cannabis laws they hope will allow the cultivation and production of hemp products for medical, food and other purposes
Other stories here: Frustrated wine-grower turns to hemp research; Patent given for CBD/CBG ‘micropearl’; GW reclaims UK rights to Sativex; Kentucky crop to be destroyed; Fight goes on over rights to cream formula
One of the 12 US regional reserve banks has complained about the banking industry’s reluctance to service hemp and CBD businesses even though they are now legal products
Legislative efforts will continue to push for cannabinoid liberalisation in the Philippines – despite recent comments that approval in principle of the epilepsy drug Epidiolex would be sufficient to cover most matters
This regulatory report covers the current situation for CBD in Belgium, looking at finished products, extracts, import and export rules and more
This week’s regulatory news in brief brings updates from the US, Colombia, Germany, Slovenia and Luxembourg
German authorities and a major European hemp association have disagreed on the implications of correspondence regarding the novel status of hemp extracts
A coalition of organisations linked to the US hemp market has released the first part of a series of policy recommendations – while one CBD firm has been referred to the US Federal Trade Commission over extravagant health claims
A bill legalising hemp and medical cannabis has been passed in Malawi, making it the fifth African country to pass some form of cannabis legalisation
Malaysia has a tough regime on hemp products. Cultivation is prohibited because hemp falls into the cannabis legal framework. The previous government had started to look into the possibility of legalising hemp cultivation and processing
This week’s regulatory news in brief brings updates from the EU, Mexico, the US, Lebanon, Malawi, Peru and the Philippines
CBD products will not be banned in the US and there is some medicinal value to them being on the market, US Food and Drug Administration (FDA) commissioner Stephen Hahn has said
The US Department of Agriculture (USDA) is to temporarily delay enforcement of two controversial provisions in its interim hemp production rule after receiving a large quantity of critical feedback
The Hemp Federation of Ireland (HFI) has taken issue with a report from the Food Standards Agency of Ireland (FSAI) and the order to remove a number of specified CBD products from shelves
Testing in the field could counter a major stated reason for enacting bans on smokable hemp in the US, but a perfect technical solution has not yet been found
Two bills in the US House of Representatives, relating to banking and medical cannabis research, appear to be dead, with not enough time to pass the measures in 2020 despite wide support
Several US hemp farmers have spoken to CBD-Intel expressing concern over the crop-testing provisions set out in the US Department of Agriculture (USDA)’s interim final rule on hemp production
The first CBD-Intel Breakfast Briefing will be held in our home city of Barcelona on 13th March, to coincide with Europe’s largest cannabis trade show, Spannabis, and is free to our valued clients and subscribers
TobaccoIntelligence, a new service from the team that produces CBD-Intel, is now available, covering the global tobacco and nicotine alternatives sector
The regulatory snapshot gives a comprehensive overview of the current regulatory landscape in Texas, detailing import and export laws, rules around vaping, cosmetic and pet food products as well as foodstuffs
A lack of clear regulation has not stopped growth for companies looking at the US CBD pet and animal sector, but for the industry to see the niche truly embraced, some solution to the regulatory issues must first be found
Switzerland’s federal supreme court has ruled CBD should not be taxed under tobacco law, meaning that hemp flowers will no longer be subject to the 25% tax under the Swiss tobacco law
This week’s regulatory news in brief brings updates from the US, Bulgaria, Ireland, Italy, Serbia, Switzerland, New Zealand, Israel and the Philippines
At a meeting of the thirteenth People’s Congress of Heilongjiang, representative Ding Fei laid out a comprehensive plan to accelerate the growth of the hemp and CBD industries in the province
Germany’s Federal Institute for Risk Assessment (BfR) recently issued a warning on e-liquids that it believed to be containing synthetic cannabinoids, after at least eight teenagers suffered medical complications from an as yet unconfirmed source
Polish lawmakers from the Permanent Subcommittee on Bioeconomy and Innovation in Agriculture at the Sejm – the lower chamber of the country’s parliament – recently hosted government officials, representatives of the Polish and the European hemp industry, and other stakeholders to discuss ways to facilitate hemp cultivation in the Polish market. The MPs have also called on the country’s Ministry » Continue Reading.
Scotland has not followed the rest of the UK in setting a deadline for novel food applications, while the Republic of Ireland has adopted an even more conservative approach, stating that unauthorised novel foods should not be on the market at all
Although CBD itself is not regulated in Peru, it is our interpretation that hemp by-products require a specific licence to be sold. This regulatory reports discusses the current rules and regulations around CBD in Peru
Our managing director Tim Phillips recently participated as a speaker at the Future Cannabis Strategies Europe 2020 in London on 29th January. Tim discussed CBD within the wider cannabis sector and provided the audience with an overview of consumer segmentation and market data. In addition, he shared how the market will evolve given the changing regulatory environment as well as » Continue Reading.
This week’s regulatory news in brief brings updates from the US, the UK, Indonesia, South Africa, Germany, Ireland, Poland and the Netherlands.
This regulatory report looks at Intellectual Property law in relation to CBD and hemp products, focusing specifically on trademarks and patents and their requirements
A proposal to regulate hemp in Italy through increasing restrictions has not got any closer to becoming a law
The current administration in the Philippines has expressed its openness to introducing cannabis products into the country, but strictly in medicinal form – contrary to what the president indicated last year
The UK’s Food Standards Agency (FSA) today set 31st March 2021 as a deadline by when the industry players must submit their novel food application
The aim of this report is to bring some clarity to the process of placing a food product on the EU market, looking at the options of Article 4 and Article 10
Reports that a CBD pain relief cream has been certified by the US Food and Drug Administration (FDA) could be construed as misleading
This report on Florida provides updated information on our last report from the end of year, specifying updates to regulation relating to seeds, foodstuffs and pet food
Peru is moving towards comprehensive legislation on cannabis but has yet to define how to classify CBD, leaving the guidelines unworkable for now
This week’s regulatory news in brief brings updates from Germany, Italy, Poland, Spain, Mexico, the US, the Bahamas, Nepal, Peru, the Philippines, South Africa, Trinidad and Tobago, and Uganda
Optimism is growing and companies are only waiting for the green light to start the production of cannabinoid products in Brazil, according to specialists
At the Pennsylvania Farm Show in Harrisburg, farmers and others were lining up to learn about a new old cash crop that’s got everyone talking: the humble hemp plant
A decree approved by Italy’s Ministry of Health has established firm limits for allowed levels of THC in edibles
The Constitutional Affairs and Budget committees of Italy’s lower house, the Chamber of Deputies, have rejected an amendment to regulate the sale of hemp or “cannabis light” products
Companies selling foods containing CBD appear to be ignoring the UK Food Standards Agency (FSA)’s latest warning about the EU’s novel foods legislation – because, some of them claim, it has no legal weight
This week’s regulatory news in brief brings updates from the US, Canada, Uganda, Israel, the Philippines, Mexico, Thailand, Australia and Europe
As the UK exits Europe and enters its 11-month period of transition, what does Brexit actually mean for cross-Channel relationships, and for the CBD industry in particular?
Federal agencies and legislators from both major US parties have all voiced a desire for more research on cannabinoids – but a major obstacle remains the lack of federally approved cannabinoids to study
Leading members of the US Congress are again pushing for the legalisation of dietary supplements containing hemp-derived CBD, currently banned by the Food and Drug Administration (FDA)
This report identifies and answers some of the most important questions surrounding the legality and regulation of CBD and food in the US
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.